KATHERINE DEVILLIER: Open Payments
NPI 1164283909 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 34 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $769 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Corium, LLC | 5 | $85 |
| Collegium Pharmaceutical, Inc. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Noven Therapeutics, LLC | 1 | $24 |
Products named: VRAYLAR, CAPLYTA, Azstarys, Jornay PM, REXULTI, FANAPT, AUSTEDO XR, Auvelity.
Industry payments across LA — which companies pay providers there.
